Implanon Nxt

Etonogestrel, the active ingredient in Implanon Nxt, is a progestin presented as a 68 mg implantable subdermal rod for subcutaneous use. It provides reversible, long‑acting contraception by preventing ovulation and fertilization in women of reproductive age through hormonal mechanisms that modify cervical mucus and the endometrium.

GNH USA supplies Implanon Nxt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution, ensuring product integrity from manufacturing to end‑user.

Etonogestrel is a progestin used in hormonal contraception to prevent pregnancy.

Contraception: Provides long‑acting reversible contraception for up to three years. Family planning: Enables reliable pregnancy prevention without daily dosing. Hormonal contraception: Suppresses ovulation and alters cervical mucus to block fertilization. Prevention of unintended pregnancy: Offers a discreet, low‑maintenance method.

Etonogestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular bleeding: Unpredictable spotting or changes in menstrual pattern. - Headache: Mild to moderate head pain. - Acne: New or worsening skin lesions. - Weight gain: Slight increase in body weight reported by some users. - Breast tenderness: Discomfort or pain in breast tissue.

Serious or Rare Side Effects: - Ectopic pregnancy: Occurs if fertilization happens outside the uterus. - Deep vein thrombosis: Blood clot formation in veins. - Allergic reaction: Rash, itching, or swelling at the insertion site. - Pelvic inflammatory disease: Infection of reproductive organs. - Implant migration: Rare movement of the rod from the insertion site. - Severe bleeding: Uncontrolled hemorrhage requiring medical attention.

Before prescribing Implanon Nxt, clinicians should consider several precautionary measures to ensure safe use.

Patient selection: Confirm the patient is not pregnant and has no contraindications to progestin use. Medical history: Review history of thromboembolic disorders, liver disease, or hormone‑sensitive cancers. Medication review: Assess concurrent use of drugs that may affect hormonal efficacy. Insertion technique: Ensure trained healthcare professional performs subdermal placement under aseptic conditions. Follow‑up: Schedule regular visits to monitor bleeding patterns and implant position. Store at ambient temperature: Keep the implant in its original packaging, protect from moisture and direct sunlight.

Etonogestrel can interact with other medicines, altering its contraceptive effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Enzyme inducers: Rifampin, carbamazepine, phenytoin may reduce hormone levels, risking contraceptive failure. - Antifungal azoles: Ketoconazole can increase hormone concentrations, potentially heightening side effects. - St. John’s wort: May decrease efficacy by enhancing metabolic clearance.

Moderate Interactions (Monitor Closely): - Antibiotics: Certain antibiotics like griseofulvin may modestly lower effectiveness; advise backup contraception. - Antiretrovirals: Some protease inhibitors can affect hormone metabolism; monitor patient closely. - Herbal supplements: Ginseng may interfere with hormone action; assess risk.